key: cord-0960540-ntxxcivo
authors: Montaño, Michalina A; Bemer, Meagan J.; Heller, Kate B; Meisner, Allison; Marfatia, Zarna; Rechkina, Elena A.; Padgett, Leah R.; Ahls, Charlotte L.; Rains, Douglas; Hao, Linhui; Hsiang, Tien-Ying; Cangelosi, Gerard A.; Greninger, Alexander L.; Cantera, Jason L.; Golden, Allison; Peck, Roger B.; Boyle, David S.; Jr, Michael Gale; Drain, Paul K.
title: Performance of anterior nares and tongue swabs for nucleic acid, Nucleocapsid and Spike antigen testing for detecting SARS-CoV-2 against nasopharyngeal PCR and viral culture
date: 2022-02-09
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2022.02.009
sha: cc9831110b46ff3ef9a24591138c8b5381c3c17e
doc_id: 960540
cord_uid: ntxxcivo

Objectives To assess performance of different swab types and specimen collection sites for SARS-CoV-2 testing, compared to reference standard RT-PCR and viral culture. Methods Symptomatic adults attending routine COVID-19 testing sites self-collected anterior nares and tongue specimens, using spun polyester and FLOQSwabs. We evaluated the anterior nares and tongue swabs by RT-PCR, nucleocapsid (N), or spike (S) antigen of SARS-CoV-2, compared to RT-PCR and viral culture from nurse-collected nasopharyngeal swabs. Results Diagnostic sensitivity was highest for RT-PCR testing by anterior nares FLOQSwabs (84%; 95% CI 68-94%) and spun polyester swabs (82%; 95% CI 66-92%), relative to RT-PCR from nasopharyngeal swabs. Relative to viral culture from nasopharyngeal swabs, diagnostic sensitivities were higher for RT-PCR and antigen testing of anterior nares swabs (91-100%) than of tongue swabs (18-81%). Antigen testing of anterior nares swabs had higher sensitivities against viral culture (91%), than against nasopharyngeal RT-PCR (38-70%). All investigational tests had high specificity compared to nasopharyngeal RT-PCR. Spun polyester swabs performed as well as FLOQswabs for anterior nasal RT-PCR testing. Conclusions Testing anterior nares specimens by RT-PCR was more sensitive than tongue swabbing or antigen testing for SARS-CoV-2. Self-collected anterior nares specimens may represent an alternative approach for diagnostic SARS-CoV-2 testing in some settings.

The existing reference standard for diagnosis of SARS-CoV-2, which causes COVID-19 disease (Gorbalenya A.E., 2020; Zhu et al., 2020) , is molecular detection by real-time reverse transcriptase polymerase chain reaction (RT-PCR) assays performed in laboratories (Cheng et al., 2020; Marty, Chen, & Verrill, 2020; Tang, Schmitz, Persing, & Stratton, 2020) . While nasopharyngeal (NP) specimens collected by trained healthcare workers may yield the most sensitive test results (FDA, 2020) , they may miss some SARS-CoV-2 infections (Guo et al., 2020; Wang et al., 2020) .

Furthermore, the deep insertion of flocked swabs into the nasopharyngeal space can be unpleasant for patients and must be collected by trained healthcare personnel wearing personal protective equipment (Marty et al., 2020) . Supply chain disruptions and increased demand during the pandemic have resulted in global shortages of flocked swabs. These challenges to specimen collection and test delivery, coupled with the increased laboratory capacity needed for scale up of COVID-19 testing, have constrained expansion of testing capacity, particularly in resource-limited settings (Cheng et al., 2020) . Identifying suitable alternative swab types, specimen types, and collection methods beyond healthcare worker-collected NP swabs for COVID-19 diagnostic tests are a priority for improving widespread implementation of COVID-19 testing.

Detection of viral RNA by RT-PCR can quantify viral load, but may not directly indicate live replicating, infectious virus (Mallett et al., 2020) . A current challenge is to understand when infected cases are non-contagious and yet have detectable SARS-CoV-2 by RT-PCR (Mardian, Kosasih, Karyana, Neal, & Lau, 2021; Walsh et al., 2020) . A study conducted among hospitalized patients with COVID-19 reported a median duration of infectious virus shedding of eight days after symptom onset, with less than 5% probability of shedding infectious virus by 15 days (van Kampen et al., 2021) .

Additional studies incorporating viral culture to measure the presence of transmissible active virus report little to no viral growth beyond 8-10 days from symptom onset, suggesting that infectivity after this time period is likely to be very low (Bullard et al., 2020; Singanayagam et al., 2020; Wölfel et al., 2020) . RT-PCR testing can detect SARS-CoV-2 far beyond this window (Singanayagam et al., 2020) , with one study reporting that 54% of repeat RT-PCR testing of already diagnosed COVID-19 patients returned positive results 10-14 days after symptom onset (Mallett et al., 2020) . Some patients continued to test positive over 30 days post-symptom onset. However, RT-PCR cycle threshold (Ct) values, which are inversely related to viral load, are strongly correlated with culturability, with probability of recovering infectious virus decreasing as Ct values increase (Singanayagam et al., 2020) . Viral culture and Ct values are likely better indicators of contagiousness than qualitative RT-PCR results alone.

Identifying accurate alternatives to RT-PCR testing of NP swabs, and tests and strategies to better identify when individuals with COVID-19 are contagious, are public health priorities. The primary objective of this study was to assess the performance of different swab types (spun polyester and FLOQSwabs), and specimen collection sites (anterior nares and tongue) for SARS-CoV-2 RT-PCR and nucleocapsid (N) and spike (S) antigen testing, when compared to reference standard RT-PCR from NP swabs. As a secondary objective we compared performance of these same investigational tests to viral culture, and related results of viral culture to NP RT-PCR Ct values and days from symptom onset.

We conducted a cross-sectional study to assess performance of SARS-CoV-2 RT-PCR and antigen tests of different swab types and specimen collection sites. Eight investigational tests were assessed: RT-PCR testing of anterior nares and tongue swab samples collected on spun polyester swabs (US Cotton v3, SteriPak #60564, Lakeland, FL), RT-PCR testing of anterior nares and tongue swab specimens collected on FLOQSwabs (COPAN Diagnostics, Carlsbad, CA), and N antigen and S antigen testing of anterior nares and tongue swab specimens collected on FLOQSwabs. Between July and October 2020, we recruited eligible participants who were 18 or older, had any symptoms of COVID-19, and were either attending a University of Washington (UW) Medicine COVID-19 testing site, a City of Seattle COVID-19 testing site, or had a documented recent positive COVID-19 RT-PCR result. Participants with recent positive COVID-19 tests were recruited by phone and asked to return to one of the COVID-19 testing sites to be re-tested and complete study visits within 7 days of their initial test. This study was approved by the UW Institutional Review Board.

Data on demographic characteristics and COVID-19 symptoms and exposure were collected via electronic questionnaires administered by research staff. Due to COVID-19 safety protocols, research staff read questions and response options aloud, and recorded participant responses in electronic REDCap data capture tools (Harris et al., 2009) . Participants self-collected research swabs with guidance from research staff. Anterior nares specimens were collected, first on spun polyester and then on FLOQswabs, by swabbing both nostrils. Tongue specimens were collected in the same order by swabbing along the length of the anterior dorsum. Clinical NP specimens were collected by clinical staff for routine RT-PCR testing, and were placed in either viral or universal transport media (VTM, UTM; Copan) and sent to the UW Clinical Virology Lab for same-day RT-PCR testing.

Research swabs were stored on site at 2 °C -8 °C upon collection and transferred to a -20 °C freezer at the end of each collection day. Anterior nares swabs and oral spun polyester swabs were stored without buffer, and oral FLOQSwabs were stored in Eagle's Minimum Essential Medium (EMEM, Sigma-Aldrich, St. Louis, MI). Residual UTM from clinical RT-PCR testing was stored at -80 °C before transportation to a BSL-3 laboratory for SARS-CoV-2 culture.

Clinical NP swabs were tested using SARS-CoV-2 RT-PCR assays on Roche Cobas 6800 Quantitative RT-PCR test results were measured as Ct values.

Anterior nares swabs were resuspended in 750 µL 1x phosphate buffered saline (PBS), pH 7.4, for 10 mins at room temperature, and the supernatant divided into 220-µL aliquots for RT-PCR and antigen testing. Tongue swab samples in EMEM were divided into 220-µL aliquots for RT-PCR and antigen testing. All aliquots were stored at -80°C until use. Anterior nares and tongue swab samples collected using FLOQSwabs were tested for SARS-CoV-2 via electrochemiluminescent (ECL) immunoassays (Debad, Glezer, Wohlstadter, & Sigal, 2004) Of 40 NP RT-PCR-positive samples, 32 had residual UTM available, and SARS-CoV-2 viral culture was performed on these samples, plus a subset of 20 randomly selected NP RT-PCRnegative residual samples. We evaluated median tissue culture infectious dose (TCID 50 ), incubation period, and plaque assays for each sample. TCID 50 was measured using Vero E6 cells expressing human angiotensin-converting enzyme 2 and transmembrane Serine Protease 2 (VeroE6AT cells) in 96-well plates with 10,000 cells in 100 µL medium seeded into each well the day before infection. On the day of infection, 500 µL UTM was filtered with spin column (Corning). Seeding medium was replaced with 90 µL medium (DMEM + 2% heat inactivated FBS + 10 mM HEPES + 1% Pen/Strep) for TCID 50 assays. 10 µL of filtered UTM was added to the 90 µL medium well as the starting inoculation before 10-fold serial dilutions were performed in the second through fourth wells. Each sample was tested in triplicate, and considered positive by SARS-CoV-2 viral culture if at least one of three plates showed SARS-CoV-2 growth. Cells were fixed with 10% formaldehyde and stained with 1% crystal violet two days after infection, digital photographs were taken, and cell death was scored.

Incubation period was further assessed by measuring the time required for virus infection to show cytopathic effect (CPE) in which VeroE6AT cells were seeded in 96-well plates as described above.

One day after seeding, the medium was replaced with Post Infection Medium (DMEM + 2% heat inactivated FBS + 1% L-Glu + 1% Ab/Am), and 10 µL UTM was added to each well to initiate infection. Plaque assays were performed directly from UTM samples using 10 µL inoculation of VeroE6TMPRSS2 cells, and were conducted using the SARS-CoV-2/Wa1 strain (Rathe et al., 2021) .

We estimated sensitivity, specificity, positive likelihood ratio (PLR) and negative likelihood ratio (NLR) for each of the eight investigational tests, as compared to two separate reference standard tests: RT-PCR and viral culture of NP swabs. All participants contributed samples for testing by NP RT-PCR and investigational RT-PCR and antigen tests. Participants without test results or with inconclusive or invalid test results for either the investigational test or the reference standard were excluded. A stratified sample of participants, based on the results of the NP RT-PCR test, was selected for SARS-CoV-2 culture, representing 80% of NP RT-PCR positive samples and 9.2% of NP RT-PCR negative samples. The participants whose samples were cultured were not a random sample of the study participants. In order for the results to be generalizable to the population giving rise to the study sample, we implemented a weighting procedure to estimate the sensitivity and specificity (Table 3 ). In particular, we separately re-weighted NP RT-PCR positive and negative samples, an approach similar to stratified survey sampling. We utilized PROC SURVEYFREQ in SAS to weight the NP RT-PCR positive samples by 1.25 and the NP RT-PCR negative samples by 10.86. This analysis assumed that the participants selected for viral culture are a stratified random sample of the sample of participants undergoing NP RT-PCR testing. We estimated 95% confidence intervals for sensitivity and specificity using the binomial exact (Clopper-Pearson) method (Clopper & Pearson, 1934) , and for PLR and NLR using the variance of the estimated PLR and NLR (Pepe, 2003) . Median quantitative results (pg/mL) were calculated for each of the investigational antigen tests, and Wilcoxon rank-sum tests were used to compare the median quantitative antigen test results for culture-positive versus culture-negative samples.

We enrolled 261 participants between July and October 2020, of whom 217 were SARS-CoV-2-negative by NP RT-PCR and 40 were SARS-CoV-2-positive. Four participants did not have RT-PCR results available, and were not included in analyses. Slightly over half of the participants had been assigned female at birth, and the median age was 37 years (Table 1 ). Almost all participants had at least one COVID-19 symptom at the time of their study visit, and participants had a median of 5 days between symptom onset and study enrollment. Of 52 samples examined for SARS-CoV-2 viral culture, 11 specimens, all from NP RT-PCR-positive participants, were culture-positive, and the remaining 41 specimens were culture-negative.

Ct values for positive NP RT-PCR test results ranged from 14.4 to 38.4 (not including those beyond LOD; Figure 1 ), and positive NP RT-PCR results were observed in participants with a wide range of days since symptom onset. Samples that were able to be cultured (culture-positive samples) came from participants on the low end of the range of days since symptom onset (1-8 days), and most had Ct values below 25. For all eight investigational tests, the median reference standard Ct value among samples with positive investigational test results was lower than the median Ct value among samples with negative results (Figure 2 ).

Using NP RT-PCR results as the reference, sensitivity varied widely across the investigational tests, and was highest for anterior nares samples tested by RT-PCR, and lowest for antigen testing of tongue swabs (Table 2) . Spun polyester swabs and FLOQSwabs performed similarly to each other.

Each anterior nares swab had higher sensitivity than its tongue swab counterpart, and antigen tests were less sensitive than RT-PCR tests relative to NP RT-PCR results. Among specimens that tested positive by NP RT-PCR, there were no substantial differences in median RNaseP value of specimens that tested positive vs. negative on any of the investigational tests.

Compared to viral culture reference standard results, sensitivity was highest for anterior nares swabs, across both swab types and both RT-PCR and antigen tests (Table 3) . Sensitivity for tongue swabs was lower, with the lowest sensitivity observed for tongue swab antigen testing. Antigen testing of anterior nares swabs was more sensitive against reference viral culture result than against reference NP RT-PCR result. In terms of overall performance, S antigen testing of anterior nares swabs corresponded best to viral culture (10 of 11 culture-positive and 39 of 41 culture-negative results correctly identified).

Compared to NP RT-PCR results, all eight investigational tests had high specificity, ranging from 98-100% (Table 2) . Weighted specificity relative to viral culture varied from 88.8% for anterior nares swab RT-PCR testing to 99.0% for S antigen testing of anterior nares swabs. The median quantitative N antigen and S antigen results from anterior nares swab testing were higher among culture-positive samples compared to culture-negative samples (N antigen: 7287.7 pg/mL vs. 0.99 pg/mL, p<0.001; S antigen: 884.2 pg/mL vs. 0 pg/mL, p<0.0001). The estimated median quantitative antigen levels were 0 pg/mL among both culture-positive and culture-negative samples for both S and N antigen testing of tongue swabs (N antigen: p=0.4; S antigen: p=0.8).

In this comparative evaluation of different tests, swab types, and specimen types, testing the anterior nares by RT-PCR was more sensitive than tongue swabbing or antigen testing for SARS-CoV-2. Spun polyester and FLOQSwabs performed similarly to each other across different test types and specimen types. Antigen testing, particularly S antigen testing, performed better relative to viral culture as opposed to NP RT-PCR. Among the samples that tested positive by NP RT-PCR, those that were successfully cultured had a narrower range of RT-PCR Ct values and days since symptom onset than those that were not successfully cultured.

A small number of studies have directly compared anterior nares specimens with NP specimens for the molecular detection of SARS-CoV-2. Among these, a study comparing selfcollected anterior nares swabs with healthcare worker-collected NP swabs tested for SARS-CoV-2 by transcription-mediated amplification documented sensitivity of 86.3% (95%CI: 76.7-92.9%), and specificity of 99.6% (95% CI: 98.0-100.0%) (Hanson et al., 2020) . A similar study comparing the accuracy of self-collected anterior nares specimens with healthcare worker-collected NP specimens, both tested via RT-PCR, reported sensitivity of 94% (one-sided 97.5% CI: 83.8-100.0%) for anterior nares specimens (Tu et al., 2020) . The results of our comparison of self-collected anterior nares swabs versus healthcare worker-collected NP swabs are similar to the above studies, and taken together, suggest that self-collected anterior nares swabs may be a viable alternative to NP swabs for SARS-CoV-2 testing.

Other studies have compared the accuracy of oral swabs to NP swabs by examining the performance of oropharyngeal (OP) swabs, and have reported variable results. A recent metaanalysis identified six studies that assessed OP versus NP swab specimens and reported that the pooled percent positive for OP swabs (84%; 95% CI: 57-100%) was similar to the pooled percent positive for NP swabs (88%; 95% CI: 73-98%), but that pooled percent agreement between OP and NP swab test results was only 68% (95% CI: 36-93%) (Lee, Herigon, Benedetti, Pollock, & Denkinger, 2021) . Percent agreement between NP and OP swab results of the included studies ranged from 24% to 95%, and the utility of OP swabs as an alternative to NP swabs for SARS-CoV-2 testing remains unclear. Few studies have specifically assessed the performance of tongue swabs compared to NP swabs. One of these reported 89.8% (97.5% CI: 78-100%) sensitivity of selfcollected tongue swabs compared to healthcare worker-collected NP swabs when both were tested by RT-PCR (Tu et al., 2020) . Conversely, sensitivity results from our comparison of self-collected tongue swabs to healthcare worker-collected NP swabs were closer to 50% for the two swab types examined. Additional study of tongue swabs as an alternate method to NP, or as a complimentary non-invasive method with anterior nares swabs, will be necessary to determine the clinical relevance of this specimen type for SARS-CoV-2 testing.

Our results add to the evidence that spun polyester swabs perform as well as other swab types for the molecular detection of SARS-CoV-2. Two recent studies found that polyester swabs may be a suitable alternative to foam swabs, with no statistically significant differences in performance (Hart et al., 2020; Padgett et al., 2021) . Another study comparing the performance of six different swab types found that polyester tipped swabs performed as well as other swab types for the detection of SARS-CoV-2, with no meaningful differences in viral yield . As inequitable vaccine distribution continues to disproportionately impact low and middle income countries (University, 2021; Usher, 2021) , ensuring access to swabs for COVID-19 testing will continue to remain a critical piece of the public health response for many countries.

The results of our examination of viral culture, days since symptom onset, and quantitative RT-PCR results are similar to prior research on this topic (Bullard et al., 2020; Singanayagam et al., 2020; Wölfel et al., 2020) . We were unable to culture samples collected after 10 days from symptom onset. One study that was able to culture samples from later in infection was conducted among patients with critical or severe COVID-19 requiring hospitalization, while our participant population were not hospitalized at the time of sample collection (van Kampen et al., 2021) . If culturability and likelihood of shedding active virus are related to severity of disease, this may explain the difference in our ability to culture samples from our study population. Ct values for participants with culturable samples in our study population tended to be lower than Ct values among participants whose samples were not able to be cultured, also similar to prior findings (Singanayagam et al., 2020) . We found that antigen testing, S antigen testing in particular, matched up with culture results better than the other intervention tests considered. In our study population, antigen testing may have been better than RT-PCR for identifying individuals who are shedding live SARS-CoV-2 virus, supporting prior research which suggests that positive antigen tests may be good indicators of infection risk to others (Routsias, Mavrouli, Tsoplou, Dioikitopoulou, & Tsakris, 2021) . If this is the case, a positive antigen test may be a better metric for determining whether an individual is contagious, and it may be useful to incorporate antigen test results for improving public health responses (Singanayagam et al., 2020) .

This study had some strengths and limitations. Our study population is not a representative sample of the population accessing SARS-CoV-2 testing in Seattle because some participants were recruited on the basis of a recent positive COVID-19 test. Due to the demographic makeup of our population and our convenience sampling approach to recruitment, these results may not be generalizable to the larger US population-and we did not estimate positive or negative predictive values. Based on their ability to travel back to study sites for research visits, and their nonhospitalized status, our SARS-CoV-2-positive participants may have had generally milder COVID-19 disease, and this may have impacted the results of RT-PCR and antigen testing, and our ability to achieve viral culture. However, the participants tested in this study may represent most unvaccinated adults being tested in ambulatory sites for SARS-CoV-2. In addition, recruiting many of our SARS-CoV-2-positive participants from among patients with a prior documented positive RT-PCR test led to a higher median number of days since symptom onset for these participants compared to our SARS-CoV-2-negative participants. This may have impacted our ability to successfully culture samples from SARS-CoV-2-positive participants. Further, differences in the buffer used to collect clinical NP specimens, elute dry anterior nares specimens, and collect tongue specimens may have had some unmeasured impact on the comparison of intervention test versus reference standard results. There may also have been uncontrollable variations in storage time at laboratories prior to testing. Finally, this study was conducted when different SARS-CoV-2 variants were circulating in the population, and it is unknown how these results may be transferable to new variants.

In conclusion, our results add to a growing body of evidence that a range of specimen collection techniques, specimen types, and swab types return accurate SARS-CoV-2 test results compared to NP RT-PCR. This is encouraging in the face of challenges to global vaccine rollout, since many countries will need to continue to scale up and incorporate SARS-CoV-2 testing in their pandemic responses. Use of self-collected anterior nares swabs may be an accurate alternative approach for diagnosing SARS-CoV-2 in some settings. Additionally, the results of our comparison of antigen testing and viral culture suggest that antigen tests may be useful for identifying whether individuals with COVID-19 have replication-competent virus. Additional research on this topic will be necessary to determine the strength of the relationship between antigen test results and infectivity, and quantify the ability of antigen test results to predict infectivity.

All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committees, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study received ethical approval from the University of Washington IRB (Ref: STUDY 00009981). Written informed consent was obtained from all individual participants included in the study.

This study was funded by the Bill and Melinda Gates Foundation, Seattle, WA. IQR: inter-quartile range; NP: Nasopharyngeal; RT-PCR: Reverse transcription polymerase chain reaction; SD: standard deviation Percentages may not add to 100 due to rounding a "Woman" combines participants who responded "woman" and "trans woman". "Man" combines participants who responded "man" and "trans man". b Participants could report any of the following symptoms experienced during the 2 weeks prior to study visit: fever, cough, shortness of breath or difficulty breathing, chills, fatigue, shaking with chills, aches or muscle pain, runny nose, sore throat, headache, loss or taste, loss of smell, nausea, vomiting, diarrhea, dizziness or vertigo, earache, or another symptom not listed prior c In some cases, participants with a recent positive COVID-19 test were included despite lack of symptoms at time of visit. d Days since symptom onset missing for 1 symptomatic participant. e Only 32 of 40 PCR-positive samples had residual UTM available for viral culture; 20 of 217 PCR-negative samples were randomly selected for viral culture True Positive a Row totals may sum to less than 217 due to exclusion of inconclusive or invalid results b 95% CIs computed using the exact binomial (Clopper-Pearson) method c 95% CIs computed using the variance of the estimated PLR and NLR NOTE: Inconclusive/invalid results excluded. Sub-sample was weighted based upon the number of NP PCR-positive and NP PCR-negative participants with viral culture results (n=20 NP PCR-negative, n=32 NP PCR-positive), respective to the total sample proportion of NP PCR results (n=217 NP PCRnegative, n=40 NP PCR-positive).

Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples

Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus 2: A Narrative Review

The use of confidence or fiducial limits illustrated in the case of the binomial

Clinical and biological applications of ECL

Food and Drug Administration COVID19 FAQs website

Comparison analysis of different swabs and transport mediums suitable for SARS-CoV-2 testing following shortages

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)

Self-Collected Anterior Nasal and Saliva Specimens versus Health Care Worker-Collected Nasopharyngeal Swabs for the Molecular Detection of SARS-CoV-2

Research electronic data capture (REDCap) -A metadata driven methodology and workflow process for providing translational researh informatics support

A comparison of health care worker-collected foam and polyester nasal swabs in convalescent COVID-19 patients

Performance of Saliva, Oropharyngeal Swabs, and Nasal Swabs for SARS-CoV-2 Molecular Detection: a Systematic Review and Meta-analysis

At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant data

Review of Current COVID-19 Diagnostics and Opportunities for Further Development

How to Obtain a Nasopharyngeal Swab Specimen

Polyester nasal swabs collected in a dry tube are a robust and inexpensive, minimal selfcollection kit for SARS-CoV-2 testing

The statistical evaluation of medical tests for classification and prediction

SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing

Diagnostic performance of rapid antigen tests (RATs) for SARS-CoV-2 and their efficacy in monitoring the infectiousness of COVID-19 patients

Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19

Laboratory Diagnosis of COVID-19: Current Issues and Challenges

Swabs Collected by Patients or Health Care Workers for SARS-CoV-2 Testing

Understanding Vaccination Progress

A beautiful idea: how COVAX has fallen short

Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)

SARS-CoV-2 detection, viral load and infectivity over the course of an infection

Detection of SARS-CoV-2 in Different Types of Clinical Specimens

Virological assessment of hospitalized patients with COVID-2019

A Novel Coronavirus from Patients with Pneumonia in China

☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work

☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests

We would like to thank the study participants for their time and for giving specimens to support our study. We recognize K. Thomas for her assistance with the analysis, R. Barney and S. Israeli for their help in preparing oral swab collection kits, L. Lillis and E. Webb for their support in preparing swab samples for analysis on the MSD platform, and the staff at the UW International Clinical Research Center, Gale Laboratory, and UW Virology Laboratory for their assistance recruiting participants, conducting study visits, and preparing and testing research specimens.